US Stock MarketDetailed Quotes

MAIA Biotechnology (MAIA)

Watchlist
  • 1.740
  • +0.150+9.43%
Trading Jan 16 14:47 ET
64.44MMarket Cap-2.35P/E (TTM)

MAIA Biotechnology (MAIA) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
1.08%-3.49M
11.73%-4.14M
-17.16%-4.2M
-20.15%-15.7M
2.11%-3.91M
-11.64%-3.52M
-82.95%-4.68M
-6.73%-3.59M
-8.06%-13.07M
-35.35%-3.99M
Net income from continuing operations
-225.41%-8.9M
39.78%-5.35M
44.01%-4.52M
-17.61%-23.25M
42.91%-3.57M
43.89%-2.74M
-96.29%-8.88M
-95.96%-8.07M
-25.39%-19.77M
-50.92%-6.26M
Operating gains losses
71.51%-379.31K
-94.96%260.6K
-119.75%-825.99K
3,364.13%6.7M
-1,996.25%-1.32M
-7,217.57%-1.33M
5,129.66%5.17M
20,066.09%4.18M
-108.48%-205.13K
-313.24%-63.2K
Other non cash items
87.31%187.31K
----
----
-75.47%179.49K
39.61%67.99K
-48.62%100K
--0
-92.99%11.5K
-33.45%731.66K
--48.7K
Change In working capital
38,773.19%4.96M
106.20%86.22K
1,338.97%769.5K
-140.11%-1.24M
-75.23%227.08K
-101.32%-12.83K
-223.81%-1.39M
-182.18%-62.11K
774.78%3.09M
35.32%916.78K
-Change in receivables
--0
--0
--0
-64.14%56.81K
-120.55%-35.75K
-51.36%129.2K
235.31%53.81K
-76.53%-90.46K
158.80%158.41K
58.66%-16.21K
-Change in prepaid assets
104.86%11.44K
277.43%104.5K
-780.79%-456.75K
-168.55%-195.94K
-79.28%31.43K
-34.65%-235.57K
-137.92%-58.89K
-56.37%67.09K
156.57%285.83K
262.91%151.69K
-Change in payables and accrued expense
5,192.49%4.95M
98.68%-18.28K
3,265.26%1.23M
-141.59%-1.1M
-70.38%231.39K
-89.38%93.54K
-237.51%-1.38M
-43.72%-38.74K
134.39%2.64M
-3.52%781.3K
Cash from discontinued investing activities
Operating cash flow
1.08%-3.49M
11.73%-4.14M
-17.16%-4.2M
-20.15%-15.7M
2.11%-3.91M
-11.64%-3.52M
-82.95%-4.68M
-6.73%-3.59M
-8.06%-13.07M
-35.35%-3.99M
Investing cash flow
Cash flow from continuing investing activities
Cash from discontinued investing activities
Financing cash flow
Cash flow from continuing financing activities
575.60%4.23M
-57.33%3.41M
15.78%5.46M
96.06%18.18M
-3.58%4.85M
397.71%626.82K
93.89%7.99M
4.72M
-25.70%9.27M
2,705.14%5.03M
Net common stock issuance
472.23%3.78M
-59.91%3.26M
13.44%5.67M
64.27%18.75M
-12.15%4.98M
--660.44K
41.25%8.12M
--4.99M
-18.30%11.42M
--5.67M
Proceeds from stock option exercised by employees
1,796.71%572.65K
77.18%328.92K
--844
15,064.66%217.16K
--1.32K
2,008.38%30.19K
--185.65K
--0
-99.69%1.43K
--0
Net other financing activities
-83.57%-117.14K
44.86%-176.63K
26.08%-204.67K
62.97%-795.26K
79.08%-134.21K
-151.25%-63.81K
---320.34K
---276.89K
-9.24%-2.15M
-203.80%-641.65K
Cash from discontinued financing activities
Financing cash flow
575.60%4.23M
-57.33%3.41M
15.78%5.46M
96.06%18.18M
-3.58%4.85M
397.71%626.82K
93.89%7.99M
--4.72M
-25.70%9.27M
2,705.14%5.03M
Net cash flow
Beginning cash position
-12.39%10.14M
31.33%10.86M
34.27%9.6M
-34.70%7.15M
42.36%8.69M
26.60%11.58M
9.03%8.27M
-34.70%7.15M
3.56%10.95M
-56.59%6.1M
Current changes in cash
125.82%748.25K
-122.02%-727.15K
11.39%1.26M
165.05%2.47M
-9.26%937.29K
4.40%-2.9M
111.85%3.3M
133.63%1.13M
-1,097.24%-3.8M
132.87%1.03M
Effect of exchange rate changes
-111.19%-1.04K
54.09%8.37K
132.19%3.06K
-18,314.53%-21.55K
-304.13%-26.77K
190.88%9.29K
469.60%5.43K
-139.38%-9.49K
97.36%-117
-56.14%13.12K
End cash Position
25.33%10.89M
-12.39%10.14M
31.33%10.86M
34.27%9.6M
34.27%9.6M
42.36%8.69M
26.60%11.58M
9.03%8.27M
-34.70%7.15M
-34.70%7.15M
Free cash flow
1.08%-3.49M
11.73%-4.14M
-17.16%-4.2M
-20.15%-15.7M
2.11%-3.91M
-11.64%-3.52M
-82.95%-4.68M
-6.73%-3.59M
-8.06%-13.07M
-35.35%-3.99M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 1.08%-3.49M11.73%-4.14M-17.16%-4.2M-20.15%-15.7M2.11%-3.91M-11.64%-3.52M-82.95%-4.68M-6.73%-3.59M-8.06%-13.07M-35.35%-3.99M
Net income from continuing operations -225.41%-8.9M39.78%-5.35M44.01%-4.52M-17.61%-23.25M42.91%-3.57M43.89%-2.74M-96.29%-8.88M-95.96%-8.07M-25.39%-19.77M-50.92%-6.26M
Operating gains losses 71.51%-379.31K-94.96%260.6K-119.75%-825.99K3,364.13%6.7M-1,996.25%-1.32M-7,217.57%-1.33M5,129.66%5.17M20,066.09%4.18M-108.48%-205.13K-313.24%-63.2K
Other non cash items 87.31%187.31K---------75.47%179.49K39.61%67.99K-48.62%100K--0-92.99%11.5K-33.45%731.66K--48.7K
Change In working capital 38,773.19%4.96M106.20%86.22K1,338.97%769.5K-140.11%-1.24M-75.23%227.08K-101.32%-12.83K-223.81%-1.39M-182.18%-62.11K774.78%3.09M35.32%916.78K
-Change in receivables --0--0--0-64.14%56.81K-120.55%-35.75K-51.36%129.2K235.31%53.81K-76.53%-90.46K158.80%158.41K58.66%-16.21K
-Change in prepaid assets 104.86%11.44K277.43%104.5K-780.79%-456.75K-168.55%-195.94K-79.28%31.43K-34.65%-235.57K-137.92%-58.89K-56.37%67.09K156.57%285.83K262.91%151.69K
-Change in payables and accrued expense 5,192.49%4.95M98.68%-18.28K3,265.26%1.23M-141.59%-1.1M-70.38%231.39K-89.38%93.54K-237.51%-1.38M-43.72%-38.74K134.39%2.64M-3.52%781.3K
Cash from discontinued investing activities
Operating cash flow 1.08%-3.49M11.73%-4.14M-17.16%-4.2M-20.15%-15.7M2.11%-3.91M-11.64%-3.52M-82.95%-4.68M-6.73%-3.59M-8.06%-13.07M-35.35%-3.99M
Investing cash flow
Cash flow from continuing investing activities
Cash from discontinued investing activities
Financing cash flow
Cash flow from continuing financing activities 575.60%4.23M-57.33%3.41M15.78%5.46M96.06%18.18M-3.58%4.85M397.71%626.82K93.89%7.99M4.72M-25.70%9.27M2,705.14%5.03M
Net common stock issuance 472.23%3.78M-59.91%3.26M13.44%5.67M64.27%18.75M-12.15%4.98M--660.44K41.25%8.12M--4.99M-18.30%11.42M--5.67M
Proceeds from stock option exercised by employees 1,796.71%572.65K77.18%328.92K--84415,064.66%217.16K--1.32K2,008.38%30.19K--185.65K--0-99.69%1.43K--0
Net other financing activities -83.57%-117.14K44.86%-176.63K26.08%-204.67K62.97%-795.26K79.08%-134.21K-151.25%-63.81K---320.34K---276.89K-9.24%-2.15M-203.80%-641.65K
Cash from discontinued financing activities
Financing cash flow 575.60%4.23M-57.33%3.41M15.78%5.46M96.06%18.18M-3.58%4.85M397.71%626.82K93.89%7.99M--4.72M-25.70%9.27M2,705.14%5.03M
Net cash flow
Beginning cash position -12.39%10.14M31.33%10.86M34.27%9.6M-34.70%7.15M42.36%8.69M26.60%11.58M9.03%8.27M-34.70%7.15M3.56%10.95M-56.59%6.1M
Current changes in cash 125.82%748.25K-122.02%-727.15K11.39%1.26M165.05%2.47M-9.26%937.29K4.40%-2.9M111.85%3.3M133.63%1.13M-1,097.24%-3.8M132.87%1.03M
Effect of exchange rate changes -111.19%-1.04K54.09%8.37K132.19%3.06K-18,314.53%-21.55K-304.13%-26.77K190.88%9.29K469.60%5.43K-139.38%-9.49K97.36%-117-56.14%13.12K
End cash Position 25.33%10.89M-12.39%10.14M31.33%10.86M34.27%9.6M34.27%9.6M42.36%8.69M26.60%11.58M9.03%8.27M-34.70%7.15M-34.70%7.15M
Free cash flow 1.08%-3.49M11.73%-4.14M-17.16%-4.2M-20.15%-15.7M2.11%-3.91M-11.64%-3.52M-82.95%-4.68M-6.73%-3.59M-8.06%-13.07M-35.35%-3.99M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions ------Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--
Market Insights
Nancy Pelosi Portfolio
China Concept Stocks
View More
The Fed Delivers Third Consecutive Rate Cut as Expected! How to Position for Year-End U.S. Equity Ma
On December 19, the Bank of Japan raised interest rates by 25 basis points as expected, in line with market forecasts. On the evening of Dec Show More